Anna Löf Granström, Ernst van Heurn, Martin Lacher, Nagoud Schukfeh, Célia Crétolle, Sabine Alexander, Annette Lemli, Marc Miserez, Anne Dariel, Francesco Fascetti-Leon, Anders Telle Hoel, Willemijn Irvine, Kristiina Kyrklund, Cecile Lambe, Cornelius E J Sloots, Merit Tabbers, Nikhil Thapar, Mikko P Pakarinen, Duccio Cavalieri, Tomas Wester, Fabio Fusaro, Kristin Bjørnland, Rony Sfeir, Niels Qvist
Journal: Journal of pediatric surgery 2024;59(10):161565
PMID: 38763854
BACKGROUND
Hirschsprung disease is a congenital intestinal motility disorder characterized by an absence of enteric ganglion cells. Total colonic aganglionosis and near total or total intestinal aganglionosis, defined as absence of ganglion cells in the entire colon and with variable length of small bowel involved, are life-threatening conditions which affect less than 10 % of all patients with Hirschsprung disease. The aim of this project was to develop clinical consensus statements within ERNICA, the European Reference Network for rare congenital digestive diseases, on four major topics: Surgical treatment of total colonic aganglionosis, surgical treatment of total intestinal aganglionosis, management of poor bowel function in total colonic and/or intestinal aganglionosis and long-term management in total colonic and or intestinal aganglionosis.
METHODS
A multidisciplinary panel of representatives from ERNICA centers was invited to participate. Literature was searched, using specified search terms, in Medline (ALL), Embase and Google Scholar. Abstracts were screened and full text publications were selected. The panel was divided in four groups that extracted data from the full text publications and suggested draft statements for each of the major topics. A modified Delphi process was used to refine and agree on the statements.
RESULTS
The consensus statement was conducted by a multidisciplinary panel of 24 participants from 10 European countries, 45 statements reached consensus after 3 Delphi-rounds. The availability of high-quality clinical evidence was limited, and most statements were based on expert opinion. Another 25 statements did not reach consensus.
CONCLUSIONS
Total colonic and total intestinal aganglionosis are rare variants of Hirschsprung disease, with very limited availability of high-quality clinical evidence. This consensus statement provides statements on the surgical treatment, management of poor bowel function and long-term management for these rare patients. The expert panel agreed that patients benefit from multidisciplinary and personalized care, preferably in an expert center.
TYPE OF STUDY
Clinical consensus statement.
LEVEL OF EVIDENCE
3a.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Full Text Sources:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.